Two and a half years ago, Cleveland Clinic researchers began a pilot study of an iPad app they’d developed as a tool for evaluating athletes after potential concussion-causing injuries.
Now it’s getting star treatment from Apple, which featured the app, called C3 Logix, as part of its “Your Verse” campaign.
The page devoted to the app gives a behind-the-scenes look at its design and some of its feature that we haven’t seen before, as it’s not available in the commercial App Store. In the promotion, Apple explains how it was used to evaluate a high school hockey player after his concussion and during his recovery.
The app prompts players to respond to a series of questions and tasks that record data about their reaction time, memory, concentration and vision. A trainer or physician can also strap the iPad around the player’s waist so the app can record information about his body sway and stability using the iPad’s gyroscope and accelerometer.
Ideally players would complete a baseline assessment at the beginning of the season that the app would compare to the post-injury data. As shown on the Apple promo, C3 uses hexagon-shaped graphs to display players’ data, so it’s easily comparable to the baseline score.
Based on the FDA’s guidance for mobile apps released last year, the app would need clearance to be marketed as a commercial product. For now, it’s reportedly being tested in a number of high schools and universities.
Check out more images here.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
